Advancing the clinical utilization of butyrate requires further optimization of its tissue specificity, pharmacokinetics, and therapeutic window
Rodriguez JM, Murphy K, Stanton C, Ross RP, Kober OI, Juge N, et al
In some embodiments, the formulation or composition comprises between about 0.01% to about 7% by weight of the viscosity modulating agent
The article's table flags gastrointestinal effects as the main additive concern, since GLP-1 medications slow gastric emptying and glutathione may alter gastrointestinal transit
Diabetology & Metabolic Syndrome, 6 , Article 80
Miami has a large, active population: athletes, gym-goers, people recovering from sports injuries, and patients dealing with chronic gut issues that never fully resolved